Department of Medicine, Division of Hematology and Hematology, University Hospitals Seidman Cancer Center, Case Western Reserve University, 11100 Euclid Ave. LKS 5079, Cleveland, OH 44106, USA.
Best Pract Res Clin Haematol. 2013 Mar;26(1):23-32. doi: 10.1016/j.beha.2013.04.003. Epub 2013 May 24.
Peripheral T-cell and NK-cell lymphomas are uncommon disorders accounting for 10-15% of all non-Hodgkin lymphomas (NHL). The NHL classification project represents the first attempt to systematically study the distribution of NHL subtypes based on a collaborative international effort and it confirmed the wide geographic variation in the frequency of different subtypes of PTCL. Subsequently, the International T-cell Lymphoma Project (ITLP), the largest collaborative international effort to date, reported prevalence and outcomes of 1314 cases of PTCL from 22 institutions worldwide with central pathology review. The ITLP consortium launched a prospective study, the T-cell project, in September 2006 aimed at collecting an exhaustive clinical and biologic data set on 1000 patients with PTCL for better definition of prognostic factors that would influence outcomes of these patients. This review aims to describe the difference in frequency and outcomes for various subtypes of PTCL based on these studies.
外周 T 细胞和自然杀伤(NK)细胞淋巴瘤是不常见的疾病,占所有非霍奇金淋巴瘤(NHL)的 10-15%。NHL 分类项目代表了首次尝试基于合作国际努力系统研究 NHL 亚型分布的尝试,它证实了不同 PTCL 亚型在频率上的广泛地理差异。随后,迄今为止最大的合作国际努力——国际 T 细胞淋巴瘤项目(ITLP)报告了来自全球 22 个机构的 1314 例 PTCL 的患病率和结局,这些病例经过中央病理审查。ITLP 联盟于 2006 年 9 月启动了一项前瞻性研究,即 T 细胞项目,旨在收集 1000 例 PTCL 患者的详尽临床和生物学数据集,以更好地定义影响这些患者结局的预后因素。本综述旨在根据这些研究描述各种 PTCL 亚型的频率和结局差异。